Revenue | ₹33.93Cr |
Net Profits | ₹-4.84Cr |
Net Profit Margins | -14.26% |
Oxygenta Pharmaceutical Ltd’s revenue jumped 0.71% since last year same period to ₹33.93Cr in the Q3 2025-2026. On a quarterly growth basis, Oxygenta Pharmaceutical Ltd has generated 138.11% jump in its revenue since last 3-months.
Oxygenta Pharmaceutical Ltd’s net profit fell -23.16% since last year same period to ₹-4.84Cr in the Q3 2025-2026. On a quarterly growth basis, Oxygenta Pharmaceutical Ltd has generated 1.83% jump in its net profits since last 3-months.
Oxygenta Pharmaceutical Ltd’s net profit margin fell -22.28% since last year same period to -14.26% in the Q3 2025-2026. On a quarterly growth basis, Oxygenta Pharmaceutical Ltd has generated 58.77% jumped in its net profit margins since last 3-months.
The revenue for Oxygenta Pharmaceutical Ltd in the Q3 results 2025 was ₹33.93Cr.
The net profit for Oxygenta Pharmaceutical Ltd in the Q3 results 2025 was ₹-4.84Cr.
The net profit margin for Oxygenta Pharmaceutical Ltd in the Q3 results 2025 was -14.26%.
The revenue for Oxygenta Pharmaceutical Ltd in the Q3 results 2024 was ₹33.69Cr.
The net profit for Oxygenta Pharmaceutical Ltd in the Q3 results 2024 was ₹-3.93Cr.
The net profit margin for Oxygenta Pharmaceutical Ltd in the Q3 results 2024 was -11.67%.